RNS Number: 6364 A Polarean Imaging PLC 22 January 2020 Polarean Imaging Plc. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, announces that yesterday it was notified that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 337,574 Ordinary Shares of £0.00037 at an...
RNS Number: 5145 Z Polarean Imaging PLC 13 January 2020 13 January 2020. Polarean Imaging plc, the medical-imaging technology company, with a proprietary magnetic resonance imaging drug-device combination, received notification on 10 January 2020 that Tyndall Investment Management now holds 4,917,016 ordinary shares of £0.00037 in Polarean, which...
RNS Number: 6117 Y Polarean Imaging PLC 02 January 2020 Polarean Imaging Plc. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 31 December 2019 that Mr Richard Hullihen, the Company's CEO, has purchased a total of 347,100 ordinary shares of £0.00037 via three...
RNS Number: 9061 X Polarean Imaging PLC 24 December 2019 Polarean Imaging Plc. The University of Iowa Hospitals and Clinics is Iowa's only comprehensive academic medical centre; an 811- bed hospital that annually admits about 37,000 patients for in-patient hospital care. Richard Hullihen, CEO of Polarean, said: "I am delighted that we have delivered and...
I discuss Polarean Imaging #POLX Open Orphan #ORPH & Metro Bank #MTRO with Justin on the Vox Markets podcast. Interview is 30 minutes in
RNS Number: 0355 T Polarean Imaging PLC 12 November 2019 Polarean Imaging Plc. New System Delivery and Installation. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product for the magnetic resonance imaging market, announces that further to the announcement of 15 February 2019, the Company has...
RNS Number: 7207 S Polarean Imaging PLC 08 November 2019 8 November 2019. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, announces that upon the recommendation of the Company's Remuneration Committee it has granted options over a total of 1,410,750 ordinary shares of £0.00037 in the...
RNS Number: 5570 S Polarean Imaging PLC 07 November 2019 7 November 2019. Completion of patient enrolment for Clinical Trials and PDMR Appointment. Polarean Imaging plc, the medical-imaging technology company, with a proprietary magnetic resonance imaging drug-device combination, announces that the enrolment for its Phase III non-inferiority clinical...
RNS Number: 6829 P Polarean Imaging PLC 11 October 2019 Polarean Imaging Plc. Polarean Imaging plc, the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 10 October 2019 that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 1,540,000 Ordinary Shares of £0.00037 at...
RNS Number: 5523 P Polarean Imaging PLC 11 October 2019 Polarean Imaging Plc. Polarean notes statement from Amphion Innovations. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2101 P Polarean Imaging PLC 09 October 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    114.44M

Featured Media

Company Profile

Polarean is manufacturer and service provider for noble gas polarizer devices and ancillary instruments with special focus on pulmonary imaging using hyperpolarized gas MRI. Current product offerings of Polarean include xenon-129 and helium-3 polarizers, polarization measurement stations and upgrade kits for existing polarizers.

Classification

Market Indices-

Locations

HQ
27-28 Eastcastle Street
London
W1W 8DH
Watchlist